Woodbury, MN, United States of America

Scott Thomas Mazar

This inventor holds 118 USPTO granted patents and 13 published patent applications and 12 EPO patents, primarily in Neurostimulator Technology (CPC class A61N1-36139). Top assignees: Cardiac Pacemakers, Inc., Livanova USA, Inc., Medtronic Monitoring, Inc.. Active years: 1997-2025.

USPTO Granted Patents = 118 

% Patents Active = 75.4

 

Average Co-Inventor Count = 3.0

ph-index = 48

Forward Citations = 9,608(Granted Patents)

Forward Citations (Not Self Cited) = 9,330(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Inver Grove Heights, MN (US) (1997 - 2015)
  • Woodbury, MN (US) (2010 - 2024)
  • Maple Grove, MN (US) (2023 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Neurostimulator
Titration Assist
Electrocardiogram
Patient Monitoring
Autonomic Response
Sleep Apnea
Physiological Sensors
Implantable Devices
Signal Analysis
Cardiac Pacing
Respiratory Rate
Data Communication
118 patents (USPTO):Explore Patents

Title: Scott Thomas Mazar: Pioneering Innovations in Neurostimulation

Introduction

Scott Thomas Mazar, based in Woodbury, MN, is a distinguished inventor with an impressive portfolio of 114 patents. Recognized for innovations that enhance neurostimulation technologies, Mazar's work has significantly contributed to advancing medical devices aimed at improving patient outcomes.

Latest Patents

Among his latest patents, Mazar has developed a method titled "Neurostimulator with Titration Assist." This innovative method involves titrating a neurostimulation signal from an initial set of parameters towards a target set, guided by a titration aggressiveness profile. A key feature of this patent is the incorporation of a hold indicator, which allows for an intermediate hold in titration, ensuring safer and more effective neurostimulation processes.

Another noteworthy patent is for "Customizable Titration for an Implantable Neurostimulator." This invention includes a programmer that collects vital data from an implantable pulse generator during the titration process, allowing real-time adjustments based on neurostimulation bursts. With its user-friendly interface and precise timing mechanisms, this technology enhances the efficiency of neurostimulation applications.

Career Highlights

Scott Thomas Mazar has held significant roles in reputable organizations such as Cardiac Pacemakers, Inc. and LivaNova USA, Inc. His experience in these companies has provided him with valuable insights that continue to shape his innovative approaches in the field of neurostimulation.

Collaborations

Throughout his career, Mazar has collaborated with talented professionals, including Yatheendhar D Manicka and Imad Libbus. These partnerships have played a crucial role in strengthening his innovative capacity, leading to the development of groundbreaking neurostimulation technologies.

Conclusion

Scott Thomas Mazar's dedication to enhancing neurostimulation techniques through innovative patents positions him as a leading figure in the medical device industry. His contributions not only underscore his expertise but also reflect a commitment to improving the lives of those in need of advanced neurostimulation therapies. As he continues to innovate, the impact of his work will likely resonate within the medical community for years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…